Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low-dosage ethambutol, less than 12.5 mg/kg/day, does not worsen the clinical outcomes of pulmonary Mycobacterium avium and Mycobacterium intracellulare disease: a retrospective cohort study.
Watanabe F, Kaburaki S, Furuuchi K, Uesugi F, Fujiwara K, Tanaka Y, Yoshiyama T, Shiraishi Y, Kurashima A, Ohta K, Hanada K, Morimoto K. Watanabe F, et al. Among authors: uesugi f. Infection. 2022 Aug;50(4):879-887. doi: 10.1007/s15010-022-01757-3. Epub 2022 Feb 1. Infection. 2022. PMID: 35106717
Clinical risk factors related to treatment failure in Mycobacterium abscessus lung disease.
Fujiwara K, Furuuchi K, Aono A, Uesugi F, Shirai T, Nakamoto K, Shimada T, Mochizuki F, Tanaka Y, Iijima H, Yoshiyama T, Shiraishi Y, Kurashima A, Ohta K, Mitarai S, Morimoto K. Fujiwara K, et al. Among authors: uesugi f. Eur J Clin Microbiol Infect Dis. 2021 Feb;40(2):247-254. doi: 10.1007/s10096-020-04026-z. Epub 2020 Sep 1. Eur J Clin Microbiol Infect Dis. 2021. PMID: 32875518
Analysis of risk factors for the development of a post-bronchoscopy respiratory infection in lung cancer patients.
Shimoda M, Yamana K, Yano R, Saitou M, Fujiwara K, Furuuchi K, Osawa T, Uesugi F, Arakawa K, Morimoto K, Tanaka Y, Kokutou H, Okumura M, Uchiyama T, Ohta K, Yoshimori K. Shimoda M, et al. Among authors: uesugi f. J Infect Chemother. 2021 Feb;27(2):237-242. doi: 10.1016/j.jiac.2020.09.029. Epub 2020 Oct 12. J Infect Chemother. 2021. PMID: 33060045 Review.
Pharmacokinetics and Adverse Effects of Clofazimine in the Treatment of Pulmonary Non-Tuberculous Mycobacterial Infection.
Watanabe F, Furuuchi K, Hanada K, Fujiwara K, Uesugi F, Hiramatsu M, Yoshiyama T, Shiraishi Y, Kurashima A, Ohta K, Morimoto K. Watanabe F, et al. Among authors: uesugi f. Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0044122. doi: 10.1128/aac.00441-22. Epub 2022 Jul 7. Antimicrob Agents Chemother. 2022. PMID: 35862744 Free PMC article.
Epidemiological characteristics of nontuberculous mycobacteriosis and bronchiectasis: comparative study using national mortality statistics from 1970 to 2015 in Japan.
Morimoto K, Iwai K, Yoshiyama T, Ito M, Uesugi F, Asakura T, Osawa T, Furuuchi K, Kurashima A, Fujiwara K, Hasegawa N, Tanaka Y, Shoji K, Shiraishi Y, Mitarai S, Ato M, Ohta K. Morimoto K, et al. Among authors: uesugi f. ERJ Open Res. 2023 Feb 20;9(1):00424-2022. doi: 10.1183/23120541.00424-2022. eCollection 2023 Jan. ERJ Open Res. 2023. PMID: 36814552 Free PMC article.
Activities of Daily Living, Hypoxemia, and Lymphocytes Score for Predicting Mortality Risk in Patients With Pulmonary TB.
Osawa T, Watanabe M, Morimoto K, Yoshiyama T, Matsuda S, Fujiwara K, Furuuchi K, Shimoda M, Ito M, Kodama T, Uesugi F, Okumura M, Tanaka Y, Sasaki Y, Ogata H, Goto H, Kudoh S, Ohta K. Osawa T, et al. Among authors: uesugi f. Chest. 2024 Feb;165(2):267-277. doi: 10.1016/j.chest.2023.09.008. Epub 2023 Sep 17. Chest. 2024. PMID: 37726072
52 results